Literature DB >> 3848335

Ferritin in erythrocytes and plasma of patients with iron overload.

H H Bodemann, R F Tanzi-Fetta, H Schröter-Urban, B A Volk, J Keul, G W Löhr.   

Abstract

Erythrocyte and plasma ferritin was followed in 13 patients with iron overload undergoing phlebotomies for at least 6 months in comparison with untreated patients and normal males. Plasma ferritin was widely scattered with an average of only twice the normal, whereas erythrocyte ferritin was highly elevated to about twelve times the normal (p less than 0.0001). - The time course of plasma and erythrocyte ferritin during phlebotomy therapy was analyzed in 3 patients with idiopathic hemochromatosis. Three stages were established: 1. plasma ferritin dropped gradually into the normal range while erythrocyte ferritin remained high, 2. appropriate phlebotomies maintained normal plasma ferritin and high erythrocyte ferritin, and indicated a monthly uptake of dietary iron of 150-200 mg at a steady state, 3. at low plasma ferritin levels, erythrocyte ferritin was rapidly decreased by further intensive phlebotomy therapy. Based on the presumed net removal of iron, 1 microgram/l plasma ferritin was equivalent to 3-6 mg of body iron and 1 microgram/l erythrocyte ferritin to somewhat less than 1 mg of body iron. - An elevated erythrocyte ferritin during phlebotomy therapy in iron overload not only depends on body iron stores like plasma ferritin but may also be regulated by the activity of erythropoiesis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3848335     DOI: 10.1007/bf00320597

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  Ferritin in formed blood elements (38539).

Authors:  D A Lipschitz; J D Cook; C A Finch
Journal:  Proc Soc Exp Biol Med       Date:  1975-02

2.  Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis.

Authors:  B Brink; P Disler; S Lynch; P Jacobs; R Charlton; T Bothwell
Journal:  J Lab Clin Med       Date:  1976-11

3.  A clinical evaluation of serum ferritin as an index of iron stores.

Authors:  D A Lipschitz; J D Cook; C A Finch
Journal:  N Engl J Med       Date:  1974-05-30       Impact factor: 91.245

4.  Biologic and clinical significance of red cell ferritin.

Authors:  M Cazzola; L Dezza; G Bergamaschi; G Barosi; V Bellotti; D Caldera; M M Ciriello; S Quaglini; P Arosio; E Ascari
Journal:  Blood       Date:  1983-11       Impact factor: 22.113

5.  Characterization of serum and red cell ferritin in hematological disorders.

Authors:  H Yamada
Journal:  Nihon Ketsueki Gakkai Zasshi       Date:  1978-12

6.  Histocompatibility antigens as markers of abnormal iron metabolism in patients with idiopathic haemochromatosis and their relatives.

Authors:  A Bomford; A L Eddleston; L A Kennedy; J R Batchelor; R Williams
Journal:  Lancet       Date:  1977-02-12       Impact factor: 79.321

7.  Erythrocyte ferritin in normal subjects and patients with abnormal iron metabolism.

Authors:  S W Peters; A Jacobs; E Fitzsimons
Journal:  Br J Haematol       Date:  1983-02       Impact factor: 6.998

8.  Normal serum ferritin concentrations in precirrhotic hemochromatosis.

Authors:  J R Wands; J A Rowe; S E Mezey; L A Waterbury; J R Wright; J W Halliday; K J Isselbacher; L W Powell
Journal:  N Engl J Med       Date:  1976-02-05       Impact factor: 91.245

9.  Hereditary hemochromatosis. Phenotypic expression of the disease.

Authors:  G E Cartwright; C Q Edwards; K Kravitz; M Skolnick; D B Amos; A Johnson; L Buskjaer
Journal:  N Engl J Med       Date:  1979-07-26       Impact factor: 91.245

10.  Erythropoiesis, iron stores and tissue iron exchange in man.

Authors:  I Cavill; C Ricketts; A Jacobs
Journal:  Clin Sci (Lond)       Date:  1979-03       Impact factor: 6.124

View more
  3 in total

Review 1.  Clinical pharmacokinetics of iron preparations.

Authors:  E Harju
Journal:  Clin Pharmacokinet       Date:  1989-08       Impact factor: 6.447

Review 2.  Molecular genetics of human chromosome 21.

Authors:  P C Watkins; R E Tanzi; S V Cheng; J F Gusella
Journal:  J Med Genet       Date:  1987-05       Impact factor: 6.318

Review 3.  Al-hijamah and oral honey for treating thalassemia, conditions of iron overload, and hyperferremia: toward improving the therapeutic outcomes.

Authors:  Salah Mohamed El Sayed; Hussam Baghdadi; Ashraf Abou-Taleb; Hany Salah Mahmoud; Reham A Maria; Nagwa S Ahmed; Manal Mohamed Helmy Nabo
Journal:  J Blood Med       Date:  2014-10-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.